Clinical Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
临床核心 - 西北大学艾滋病毒/艾滋病和新发传染病即时护理技术创新中心 (C-THAN)
基本信息
- 批准号:10762201
- 负责人:
- 金额:$ 34.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-11 至 2028-07-31
- 项目状态:未结题
- 来源:
- 关键词:AdoptionCOVID-19 diagnosticCOVID-19 point of careCaregiversCharacteristicsChicagoClinicalClinical DataClinical InvestigatorClinical ResearchCollaborationsCommunicable DiseasesCommunitiesCommunity Health NetworksDedicationsDevelopmentDevicesDiagnosisDiagnosticEmerging Communicable DiseasesEngineeringEnrollmentEvaluationFDA Emergency Use AuthorizationFacultyFogarty International CenterFundingGoalsGrantHIVHIV/AIDSHealthHomeHumanIllinoisIndividualInfrastructureInstitutionInternationalLaboratoriesLeadershipMaliMethodologyNational Institute of Biomedical Imaging and BioengineeringNigeriaParticipantPatientsPerceptionPerformancePilot ProjectsPoint of Care TechnologyProtocols documentationPublic HealthPublic Health PracticeRADxRADx TechResearchResearch DesignResearch PersonnelResearch Project GrantsResearch TrainingResource-limited settingReverse Transcriptase Polymerase Chain ReactionSampling StudiesSenegalServicesSiteSouth AfricaTanzaniaTechnologyTechnology AssessmentTestingTrainingTraining ProgramsTranslationsU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesValidationWorkclinical research sitecommunity settingcomorbiditydata repositoryexperienceinnovationlow and middle-income countriesmanufacturemedical schoolsnovelpandemic diseasepoint of careprogramsprototyperesearch clinical testingsocial culturesuccesstechnology developmenttechnology research and developmentuptakeusabilityvalidation studiesvirtual repository
项目摘要
SUMMARY – CLINICAL CORE
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious
Diseases at Northwestern University (C-THAN) will continue to be a vital partner in the NIBIB Point-of-Care
Technologies Research Network (POCTRN) of Technology Research and Development Centers (TRDCs).
The C-THAN Clinical Core will benefit from many years of infectious diseases-focused research and training
with clinical sites in Nigeria, South Africa, Mali, Senegal, and Tanzania. In addition to our key academic
partners, we will integrate many other international, national, regional and community stakeholders involved in
POC and home-based technology development across the partner institutions. Our overarching objective is to
develop a pipeline of POC and home-based technologies that meet the clinical needs of individuals with
HIV/AIDS and emerging infectious diseases (EID) in low and middle-income countries (LMICs). Investigators
will be required to demonstrate analytical and clinical performance of technologies as well as usability in low
resource settings. The Clinical Core specific aims are: 1. validate and establish protocols for innovative POC
and home-based technologies developed for the diagnosis and management of HIV/AIDS, HIV-related co-
morbidities, and EID in “real-world” clinical or community settings. 2. assess clinical user (caregiver and
patient) perceptions of device usefulness, acceptability within the sociocultural context, friendliness, and
comfort of HIV/AIDS and EID POC and home-based technologies, and 3. support translation of innovative
POC and home-based technologies from the Development Core into clinical studies though pilot funding,
expertise in clinical validation study design, and providing services including biospecimens with clinical data.
Our Clinical Core will continue to provide a “clinical laboratory” for innovators that will focus on validation and
user assessment of POC and home-based diagnostics on HIV/AIDS and EID. Depending on the status of a
developing POC technology, we will work across Cores to select projects to participate in either the Clinical
Core or Technology Core. The primary goal of the Clinical Core is to provide infrastructure and services
dedicated to clinical validation (from stored samples or clinical studies) and to evaluate clinical user
acceptability to ensure that the POC technology prototypes supported under this program have a high rate of
success for clinical uptake and maximal public health impact.
总结-临床核心
艾滋病毒/艾滋病和新兴传染病护理点技术创新中心
西北大学(C-THAN)的疾病将继续成为NIBIB护理点的重要合作伙伴
技术研究和发展中心的技术研究网络。
C-THAN临床核心将受益于多年以传染病为重点的研究和培训
在尼日利亚、南非、马里、塞内加尔和坦桑尼亚设有临床基地。除了我们的主要学术
我们将与许多其他国际、国家、区域和社区利益攸关方合作,
合作机构的POC和基于家庭的技术开发。我们的首要目标是
开发POC和基于家庭的技术管道,满足个人的临床需求,
低收入和中等收入国家的艾滋病毒/艾滋病和新出现的传染病。调查人员
将被要求证明技术的分析和临床性能以及在低
资源设置。临床核心的具体目标是:1。验证和建立创新POC的协议
和家庭为诊断和管理艾滋病毒/艾滋病开发的技术,与艾滋病毒有关的合作,
发病率,以及“现实世界”临床或社区环境中的EID。2.评估临床用户(护理人员和
患者)对器械有用性、社会文化背景下的可接受性、友好性的感知,以及
舒适的艾滋病毒/艾滋病和EID POC和家庭为基础的技术,和3。支持翻译创新
通过试点资助,将POC和基于家庭的技术从开发核心转化为临床研究,
临床验证研究设计方面的专业知识,并提供包括生物样本和临床数据在内的服务。
我们的临床中心将继续为创新者提供一个“临床实验室”,重点是验证和
对艾滋病毒/艾滋病和早期感染者进行POC和家庭诊断的用户评估。根据一个
在开发POC技术时,我们将与核心公司合作,选择参与临床研究的项目,
核心或技术核心。临床核心的主要目标是提供基础设施和服务
专门用于临床验证(来自储存的样本或临床研究)和评价临床用户
可接受性,以确保该计划下支持的POC技术原型具有较高的
临床应用的成功和最大的公共卫生影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chad J Achenbach其他文献
South Asia’s COVID-19 History and Surveillance: Updated Epidemiological Assessment (Preprint)
南亚的 COVID-19 历史和监测:更新的流行病学评估(预印本)
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:8.5
- 作者:
L. Post;Alan G. Soetikno;Scott A. Wu;Claudia Hawkins;Maryann Mason;E. Ozer;Robert Murphy;Sarah B. Welch;Yingxuan Liu;R. J. Havey;Charles B Moss;Chad J Achenbach;Alexander L Lundberg - 通讯作者:
Alexander L Lundberg
HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients HIV Viremia and Incidence of Non-Hodgkin Lymphoma in Patients Successfully Treated With Antiretroviral Therapy Successfully Treated With Antiretroviral Therapy
成功接受抗逆转录病毒治疗的患者中的 HIV 病毒血症和非霍奇金淋巴瘤的发病率 成功接受抗逆转录病毒治疗的患者中的 HIV 病毒血症和非霍奇金淋巴瘤的发病率
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
Chad J Achenbach;Ashley L. Buchanan;Stephen R. Cole;Lifang Hou;M. Mugavero;Heidi M Crane;Richard D. Moore;Richard H. Haubrich;Satish Gopal;Joseph J Eron;Peter W Hunt;B. Rodriguez;Kenneth H. Mayer;M. Saag;M. Kitahata - 通讯作者:
M. Kitahata
Sub-Saharan Africa Surveillance Metrics and History of the COVID-19 Pandemic: Updated Epidemiological Assessment (Preprint)
撒哈拉以南非洲地区的监测指标和 COVID-19 大流行的历史:更新的流行病学评估(预印本)
- DOI:
- 发表时间:
2023 - 期刊:
- 影响因子:8.5
- 作者:
Alexander L Lundberg;Alan G. Soetikno;Scott A. Wu;E. Ozer;Sarah B. Welch;Maryann Mason;Robert Murphy;Claudia Hawkins;Yingxuan Liu;Charles B Moss;R. J. Havey;Chad J Achenbach;L. Post - 通讯作者:
L. Post
Chad J Achenbach的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chad J Achenbach', 18)}}的其他基金
Administrative Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
行政核心 - 西北大学艾滋病毒/艾滋病和新发传染病即时护理技术创新中心 (C-THAN)
- 批准号:
10762199 - 财政年份:2018
- 资助金额:
$ 34.8万 - 项目类别:
The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
西北大学艾滋病毒/艾滋病和新发传染病即时护理技术创新中心 (C-THAN)
- 批准号:
10762198 - 财政年份:2018
- 资助金额:
$ 34.8万 - 项目类别:
相似海外基金
Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.
等离子 PCR:快速护理点 COVID-19 诊断平台。
- 批准号:
422581 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Operating Grants
Developing Multiplexed COVID-19 Diagnostic Methods for Medical Surveillance
开发用于医疗监测的多重 COVID-19 诊断方法
- 批准号:
555046-2020 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Alliance Grants
AgPlus Electrochemical COVID-19 Diagnostic Assay
AgPlus 电化学 COVID-19 诊断分析
- 批准号:
69258 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Feasibility Studies
Streamlining RNA extraction for widespread COVID-19 diagnostic testing
简化 RNA 提取以进行广泛的 COVID-19 诊断测试
- 批准号:
550402-2020 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Alliance Grants
Enhancing National COVID-19 Diagnostic Support Capacity in Uganda
加强乌干达国家 COVID-19 诊断支持能力
- 批准号:
MC_PC_19062 - 财政年份:2020
- 资助金额:
$ 34.8万 - 项目类别:
Intramural